Search

everythinglearnresearchcommunity

for

Search:↓

Several new hair loss treatments are in development, with Cosmo Breezula and Kintor KX826 being the furthest along, expected to be commercialized by 2027. Veradermics is the only treatment in pill form, while others like KX/GT/Breezula will be topical.

The user has been using a daily capsule containing 1mg finasteride and 2.5mg minoxidil for 11 months, with noticeable regrowth on the crown but minimal improvement on the hairline. They experienced no significant side effects and plan to continue the treatment long-term.

The user reported significant hair growth progress after six months using daily Dutasteride 0.5mg and oral Minoxidil 5mg. Many users expressed amazement and inquired about side effects, age, and product brands.

User has been using topical Minoxidil (5%) and Finasteride (0.1%) for 5-6 months, along with a dermaroller. No side effects reported, but user notes weight gain without change in diet or exercise.

KPV, a peptide patented by L'Oreal, may promote hair growth and reduce hair loss by extending the anagen phase and has anti-inflammatory properties. It could be combined with treatments like minoxidil for enhanced effects.

The conversation is about someone's hair transplant progress after 8 months, questioning if results will improve. They use topical minoxidil and finasteride, a dermapen, vitamins for hair, and aminexil shampoo, and sometimes do scalp massages.

The user shared a 6-month update on using dutasteride, minoxidil, and a dermaroller for hair regrowth, reporting positive progress. Other users discussed switching from finasteride to dutasteride, with mixed opinions on effectiveness and side effects.

The conversation discusses new hair loss treatments like stem cell therapy, exosome treatments, and DHI, with mentions of GT20029, Amp303, and Plated PRP Serum as promising options. It also notes the use of dutasteride, topical finasteride, and minoxidil, but the focus is on non-hormonal innovations.

The conversation discusses the potential release of Winlevi in 2019 by Cassiopeia for hair loss treatment. It suggests a regimen combining minoxidil, Winlevi, Nizoral, and possibly dermarolling, with a comment mentioning Breezula as an alternative to finasteride without side effects.

A user's progress after taking finasteride and minoxidil for 6 months, as well as adding other treatments such as keto shampoo, trentinoin, and derma rolling. Replies include advice to keep going and the suggestion of considering a hair transplant.

A user shared an extensive hair loss treatment regimen including dutasteride, minoxidil, tadalafil, RU58841, microneedling, and various topical and oral supplements. Responses varied, with some suggesting the regimen is excessive and others offering additional advice or expressing skepticism about its practicality and effectiveness.

PP405, a topical treatment, shows promise for hair growth by activating inactive follicles, with 66% of participants experiencing positive results. The treatment is well-tolerated and may proceed directly to Phase 3 trials, offering a potential alternative to minoxidil and finasteride.

Amplifica starting clinical trials for new hair loss drug. SCUBE3 protein discovered, stimulates hair growth, could be alternative to Minoxidil and Finasteride.

A 21-year-old shared their 6-month hair regrowth journey using daily finasteride tablets and once-daily topical minoxidil, noting significant improvement in hair thickness, especially at the corners, with minimal side effects. They also mentioned using minoxidil for beard growth with limited success and occasionally using a dermaroller.

The user has been using finasteride and minoxidil for 11 months but experienced hair thinning after adding topical dutasteride. They plan to continue with Lipogaine, finasteride, and a reduced frequency of topical dutasteride, along with dermarolling and biotin.

The user has been using Minoxidil for 4 years and recently added a derma pen and Trinov to their regimen, but results are inconclusive after 3 months. Some users suggest Trinov is ineffective and recommend alternatives like Clascoterone (Breezula) for better results.

9-month progress using Minoxidil and Finasteride for hair loss. Users discuss treatments, vitamins, and microneedling.

A group buy for testing a compound targeting Twist1 protein as a potential hair loss treatment. Inhibiting Twist1, which keeps hair follicles in growth phase, may prevent hair loss with minimal side effects.

A user switched from finasteride to dutasteride after 6.5 years due to hair thinning and may add oral minoxidil if needed. They are worried about shedding and side effects but hope for better hair density with dutasteride.

The conversation discusses Peptonix microneedling, a copper peptide serum, as a potential hair loss treatment. Users compare it to finasteride and minoxidil, noting side effects and personal experiences with these treatments.

The conversation is about hair loss treatments, specifically using finasteride, minoxidil, and biotin, with a focus on the effectiveness of Hims products. Users discuss the results, potential side effects, and the role of biotin in the treatment.

PP405 is a promising new treatment for hair loss that activates dormant stem cells in hair follicles, potentially bypassing the effects of DHT. It is currently in phase 2 trials and could be available between 2027 and 2030, but it is not considered a definitive cure.

GT20029 and CosmeRNA are both potential hair loss treatments; GT20029 breaks down the androgen receptor, while CosmeRNA prevents its production. Continuous use is needed, but less frequently than current treatments like Minoxidil and Finasteride.

The conversation is about a person's 6-week progress using 2.5 mg oral minoxidil, 0.5 mg dutasteride, weekly derma stamping at 1.5 mm, and rosemary oil for hair loss, with some initial shedding but no side effects. They are optimistic about future results.

Progress made in treating hair loss using Dustasteride, topical Minoxidil and microneedling.

The conversation discusses skepticism about group buys for hair loss treatments, highlighting issues with unverified chemicals and the risks involved. It suggests stabilizing with dutasteride and minoxidil, and considering a hair transplant instead of experimenting with untested products.

PP405 is a new hair loss treatment advancing quickly in trials, generating excitement and skepticism about its effectiveness and marketing claims. Some see it as a potential alternative to minoxidil and finasteride, but concerns about long-term effects and the need for DHT blockers persist.

An 18-year-old has been using finasteride and minoxidil for hair loss, experiencing increased shedding and thinning despite treatment. They are considering switching to dutasteride and are seeking advice from others with similar experiences.

Minoxidil, PRP, low-level light therapy, stem cell therapy, mesotherapy, Acell, and microneedling are discussed as treatments for thickening fine hairs in NW5 hair loss sufferers. A hair transplant may be necessary for significant improvement.

Hmi115, a prolactin receptor blocker, showed promise for hair growth, but results from Phase 2 trials have not been published. ABS-201, an AI-based analog, is expected to begin trials in December 2025, while commercialization of treatments like PP-405 is anticipated around 2027.